Trial intelligence / Profile preview

Heparin vs normal saline for maintaining central venous catheter patency

IRCT2014050613156N5Phase 2Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Apr 2014
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised trial of heparin (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Central venous catheter patency. Started Apr 2014; status: completed.

02

Drugs

heparin

Beyond the preview

Go deeper on IRCT2014050613156N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014050613156N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call